Search In this Thesis
   Search In this Thesis  
العنوان
STUDY OF MICRO RNA 152-3p EXPRESSION AS A BLOOD BASED BIOMARKER FOR DIABETIC NEPHROPATHY IN TYPE 2 DIABETES /
المؤلف
IBRAHIM, KHALED MOSTAFA FEKRY.
هيئة الاعداد
مشرف / خالــد مصطفـى فكـرى إبراهـيــم
مشرف / وليد محمد النبوى
مشرف / ثريا محمد أحمد
مشرف / منى زكى شريف
الموضوع
Diabetic nephropathies. Diabetes Mellitus, Type 2. Diabetic nephropathies Congresses. Diabetic nephropathies therapy.
تاريخ النشر
2019.
عدد الصفحات
120 p. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
الطب الباطني
الناشر
تاريخ الإجازة
26/7/2019
مكان الإجازة
جامعة بني سويف - كلية الطب - الباطنة العامة
الفهرس
Only 14 pages are availabe for public view

from 141

from 141

Abstract

Summary
Type 1 and type 2 DM have severe complications including DN. Diabetic nephropathy is one of the commonest causes of CKD.
Much research effort is being put into how to diagnose DN in diabetic patients. A large number of biomarker studies were published on markers in plasma or urine, either aiming to distinguish patients with or without DN, or with aiming to expect renal outcome in those patients with DN.
This cross-sectional observational study recruited 50 patients with longstanding T2DM and 20 healthy control subjects. Patients with T2DM were further stratified according to their urine albumin–creatinine ratio (UACR) into 3 groups ; normoalbuminuric , microalbuminuric and macroalbumuinuric . has miR-152 – 3p was quantified in blood using reverse transcription TaqMan microRNA assay..
The study showed that the has miR-152 – 3p levels were significantly higher in patients with lower eGFR and higher albumin/creatinine ratio
These findings may help to find a new marker for early detection of DN and this could be used in the future as a novel therapeutic target for the treatment of DN.